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Abstract
Introduction: In the Czech Republic, screening of glucose tolerance disorders is per-
formed in all pregnant women in two stages: measuring glycaemia in a fasting patient 
within 14 weeks of pregnancy, and between the 24th and 28th weeks by performing an oral 
glucose tolerance test (oGTT). Goal: To determine how the oGTT is performed from the 
point of view of pregnant women.
Materials and Methods: A total of 134 women in their 35th–44th week of pregnancy com-
pleted a non-standardized questionnaire. The research was carried out at workplaces in 
Zlín.
Results: Only three respondents knew how many grams of glucose are drunk for an oGTT 
and one stated that it is necessary to fast for 8 hours before an oGTT. Capillary blood was 
taken in 22 cases, which is unacceptable in relation to recommendations.
Conclusions: Inadequate knowledge concerning the preparation and performance of the 
oGTT may lead to distorted laboratory results.
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Introduction
Gestational diabetes mellitus (GDM) is deﬁ ned as any glucose intolerance cor-
responding to the criteria for diabetes mellitus, increased glycaemia in a fasting 
patient, or disrupted glucose tolerance, which is ﬁ rst diagnosed during pregnancy. 
GDM usually passes after childbirth, but it might also be the ﬁ rst interception of 
diabetes, mainly in the case of its early interception (before the 20th week of preg-
nancy). Untreated GDM poses a whole range of short-term and long-term risks 
for both the mother and the foetus: the risk of preeclampsia, premature childbirth, 
Caesarean section birth, foetal macrosomia, hyperbilirubinemia, newborn hypo-
glycaemia, shoulder dystocia, and the necessity of intensive neonatal care (the 
HAPO study – Hyperglycaemia and Adverse Pregnancy Outcome – performed 
on a sample of over 23,000 pregnant women). Untreated GDM also poses long-
term risks of obesity, metabolic syndrome, type-2 diabetes mellitus, and the risk 
of intellect damage in oﬀ spring. Randomized studies have proved the eﬃ  cacy 
of GDM treatment that results in a decrease in the occurrence of preeclampsia 
and risks for newborn babies. A woman with GDM in her medical history has 
a higher risk of developing DM later in life [1,2,3].
Currently, screening of glucose tolerance disorders (GTD) is indicated in 
all pregnant women except those already diagnosed with prediabetes (Impaired 
Fasting Plasma Glucose or Impaired Glucose Tolerance) or diabetes. Screen-
ing is ensured by the attending gynaecologist and is performed in two stages. 
According to the Czech Society for Gynaecology and Midwifery (ČGPS) and 
the Czech Medical Society of Jan Evangelista Purkyně (ČLS JEP), all pregnant 
women must undergo the ﬁ rst screening stage in the 14th week of pregnancy. They 
undergo a glycaemia examination on an empty stomach in venous plasma using 
a standard laboratory method. All women whose test in the ﬁ rst trimester was 
negative undergo the second screening stage between the 24th and 28th weeks of 
pregnancy; the so-called 3-point 75g oGTT [1,3].
3 days prior to testing, pregnant women adhere to their usual diet (un-
limited intake of sugars and no increased physical eﬀ ort one day prior to test-
ing). The test itself is performed in the morning after fasting for at least 8 hours 
(they are only allowed to drink clear water). All samples must be taken from 
a vein. Capillary blood from a ﬁ nger is not permitted. An  individual glycaemia 
must be determined using a standard method no later than one hour after taking 
the sample. For this whole period, the women are kept physically calm in the 
laboratory. They are not allowed to smoke before or during the testing. Regular 
doses of medicines with anti-insulin eﬀ ects (namely hydrocortisone, thyroxin, 
beta sympathomimetics, progesterone, etc.) can be applied on testing day only 
on completion of the test. Diagnostic procedure: glycaemia is ﬁ rst established on 
an empty stomach and is then proceeded based on the level of fasting glucose. 
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If glycaemia on an empty stomach is below 5.1 mmol/l the woman undergoes 
a 75 g oGTT. She then drinks a solution of 75 g of glucose dissolved in 300 ml 
of water, which should take no more than 3–5 minutes. Another blood sample is 
taken 60 and 120 minutes later, respectively, after glucose load. With glycaemia 
on an empty stomach ≥ 5.1 mmol/l, it is necessary to repeat glycaemia as soon as 
possible, but not on the same day. With repeated glycaemia on an empty stomach 
< 5.1 mmol/l, the woman undertakes a 75 g oGTT. If there is repeated glycaemia 
on an empty stomach ≥ 5.1 mmol/l, the woman has GDM. Such a woman does 
not undergo an oGTT.
Result evaluation and further procedure: if all glycaemia results are normal 
(that is, on an empty stomach < 5.1 mmol/l; in 1 hour after load < 10.0 mmol/l, 
in 2 hours after load < 8.5 mmol/l), it is a negative screening and standard care 
continues. GDM diagnosis is determined if at least one value in the test is patho-
logical. If it is GDM, the woman is sent to the department of diabetology.
Until now—both globally and in the Czech Republic—there was an incon-
sistency in the criteria for performing screening, which led to misinterpretations 
of how to correctly perform PGT screening.
Goal: To determine how the oral glucose tolerance test is performed in prac-
tice between the 24th and 28th weeks, from the perspective of pregnant women.
Materials and Methods
A total of 134 women in the 35th – 44th week of pregnancy completed a non-
standardized questionnaire. The research was carried out at workplaces in Zlín.
Basic data on the test subjects is shown in Tab. 1 (the number of respond-
ents, average age, week of pregnancy in which the women completed the ques-
tionnaire, and the week when they underwent the oGTT). This research project 
was approved by the managers of the relevant workplaces.
 Table 1. Basic data on pregnant women who completed the questionnaire
N Age [years]
[x— ]
(min-max)
Completing 
the question-
naire – week 
of pregnancy
Undergoing 
oGTT
[x— ]
(min-max)
First-time 
pregnant 
women
Second-time 
pregnant 
women
Third-time-
plus preg-
nant women
134 31 years 
(16–42)
38th month 25th week
(23–28)
69 41 24
Legend: n – number of days in the group, x— – arithmetical mean
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Results
134 pregnant women took part in the survey. 69 (52%) ﬁ rst-time pregnant wom-
en, 41 (31%) second-time pregnant women, and 24 (18%) third-time-plus preg-
nant women took part in the research. The group consisted of 63 women with 
completed high school graduation (47%), and 42 (31%) with a college degree. 
Only 3 women had only elementary education, and 26 (19%) had high school 
education without a graduation examination.
The respondents mentioned that they had undergone an oGTT in the 25th 
week of pregnancy on average for the following reasons: a) it was their doctor’s 
wish – in 69 cases; b) because diabetes was diagnosed in the family – in 23 cases; 
c) no explanation was given – in 17 cases; in 17 cases, an increased level of sugar 
was measured.
Only three respondents knew how many grams of glucose are drunk for an 
oGTT. Only one stated that it was necessary to fast for 8 hours before an oGTT. 
They mostly stated a shorter (40%) or longer (37%) period of fasting, or did not 
clearly express themselves regarding the fasting period (22%). In 22 cases (16%), 
they stated that blood had been taken during an oGTT. In 48 cases (38%), the re-
spondents stated that they felt bad after consuming the sweet liquid; mostly they 
felt sick. Despite the respondents’ conﬁ rmed ignorance regarding the preparation 
and performance of the oGTT, they were extremely or very satisﬁ ed with the 
process of being informed (57%).
Discussion
The average age of the pregnant women corresponds to the current trends (31 
years). According to ČSÚ (2013), in all European countries including the Czech 
Republic, people tend to postpone parenthood to a later age. In the Czech Repub-
lic, the average age of the mother at the time of giving birth to her ﬁ rst child in-
creased from 22.5 years in 1990 to 27.9 years in 2012. It is, among others, caused 
by a high occurrence of parents with a college degree.
GDM aﬀ ects genetically predisposed women, with many risk factors af-
fecting its manifestation. GDM is largely caused by insulin resistance, which 
starts occurring in the second trimester and progresses in the third. [4] There is 
no international consensus regarding the timing of the screening method and the 
optimal cut-oﬀ  points for diagnosis and intervention of GDM. [5]. The Czech Re-
public adheres to the recommendations of ADA/IADPSG for screening women at 
risk of diabetes. In Poland, the diagnosis of GDM is based on the recommenda-
tions of the Polish Gynaecological Society (PTG) and is usually performed by 
obstetricians in compliance with international recommendations. [6].
In the Czech Republic, as in Poland, screening of glucose tolerance defects 
(GTD) is done in two stages: a fasting glucose test is taken in the 14th week of 
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pregnancy and between the 24th and 28th weeks by performing the oral glucose 
tolerance test (oGTT). [7].
It is very positive that on average the respondents had the test in the 25th 
week of pregnancy. However, 16 of them stated that they did not know in what 
week they had the test, and 10 refused to have it. A large number of respondents 
69 (52%) stated that they had undergone the oGTT based on their doctor’s wish. 
In 17 cases, no reason was stated. Women should be fully informed that they 
undergo the test to ensure healthy development of the foetus, not simply for their 
doctors. In 17 cases, a higher level of sugar was measured, and in 2 cases the 
respondents stated that they had been diagnosed with diabetes mellitus. As far 
as the procedure itself is concerned, there are big information gaps. Only three 
respondents knew how many grams of glucose are administered during an oGTT. 
Only 1 stated that it was necessary to fast for 8 hours prior to the oGTT, which 
means that they were not adequately prepared for the examination itself. In 22 
cases (16%), they stated that blood had been drawn from their ﬁ ngers during an 
oGTT, which is unacceptable in accordance with both Czech and international 
recommendations. Again, such examinations were thus distorted. Despite con-
ﬁ rmed ignorance on the part of the respondents regarding the preparation for 
and performance of the oGTT, 57% were satisﬁ ed or even very satisﬁ ed with the 
information being conveyed to them. The Polish study (Moleda P, Fronczyk A., et 
al.)—where the aim of the study was to assess practical implementation of PTG 
standards of GDM screening and diagnosis in 351 pregnant women who con-
sulted a diabetologist—consisted of 102 patients between 2008 and 2010 (PTG 
guidelines of 2005), and 249 patients between 2011 and 2013 (PTG guidelines 
of 2011). Adherence to the diagnostic guidelines for 2008–2010 was 42.2%. The 
most common errors were incorrect time of the oGTT (36.4%) and wrong inter-
pretation of glycaemia (34.1%). Between 2011 and 2013, incorrect diagnostic 
testing was detected in 78.3% of aﬀ ected women. The most common deviation 
was a lack of oGTT at the beginning of pregnancy in women with GDM risk fac-
tors (91.3%) [6].
Untreated DM can cause many short-term and long-term risks for both the 
pregnant woman and the foetus. In pregnant women with pre-existing diabetes, 
we can observe a tendency to develop complications, e.g. progression of diabetic 
retinopathy, diabetic nephropathy, and diabetic cardiomyopathy. Based on the 
aforementioned facts, there are counter-indications for pregnant women, which, 
however, need to be assessed in their full complexity and in respect to the overall 
clinical condition and laboratory results [8,9,10].
Conclusions
We assume that inadequate information both on the part of healthcare profession-
als and the pregnant women themselves regarding the preparation and perfor-
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mance of the oGTT may lead to distorted laboratory results, and thus late diag-
nostics of GDM. We will continue in our research using the qualitative method.
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